Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Barrow

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|November 25, 2004
Functional cloning of Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprimEsther W Barrow, Philip C Bourne, William W Barrow
Revue Scientifique Et Technique (International Office of Epizootics)|April 6, 2001
Treatment of mycobacterial infectionsW W Barrow
Current Pharmaceutical Design|November 17, 2004
Microsphere technology for chemotherapy of mycobacterial infectionsWilliam W Barrow
Research in Microbiology|May 1, 1991
Contributing factors of pathogenesis in the Mycobacterium avium complexW W Barrow
Kentucky Medical Journal|March 19, 2010
Recent advances in surgeryD W BARROW
Frontiers in Bioscience : a Journal and Virtual Library|August 15, 1997
Processing of mycobacterial lipids and effects on host responsivenessW W Barrow
International Journal of Antimicrobial Agents|January 21, 2006
Newly developed colorimetric drug screening assay for Bacillus anthracisEsther W Barrow, Michelle Wright Valderas, Philip C Bourne, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2007
In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracisEsther W Barrow, Jürg Dreier, Stefan Reinelt, et al.
Chemico-Biological Interactions|July 1, 1979
Chemical and ultrastructural examination of lead-induced morphological convertants of Bacillus subtilisW Barrow, T G Tornabene
Research in Microbiology|March 1, 1994
Laboratory and clinical aspects of the Mycobacterium avium epidemic: contributing factors associated with variability of drug susceptibility and immune responsiveness, and the multifaceted nature of pathogenicityN Rastogi, W W Barrow
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|November 25, 2004
Functional cloning of Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprimEsther W Barrow, Philip C Bourne, William W Barrow
Revue Scientifique Et Technique (International Office of Epizootics)|April 6, 2001
Treatment of mycobacterial infectionsW W Barrow
Current Pharmaceutical Design|November 17, 2004
Microsphere technology for chemotherapy of mycobacterial infectionsWilliam W Barrow
Research in Microbiology|May 1, 1991
Contributing factors of pathogenesis in the Mycobacterium avium complexW W Barrow
Kentucky Medical Journal|March 19, 2010
Recent advances in surgeryD W BARROW
Frontiers in Bioscience : a Journal and Virtual Library|August 15, 1997
Processing of mycobacterial lipids and effects on host responsivenessW W Barrow
International Journal of Antimicrobial Agents|January 21, 2006
Newly developed colorimetric drug screening assay for Bacillus anthracisEsther W Barrow, Michelle Wright Valderas, Philip C Bourne, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2007
In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracisEsther W Barrow, Jürg Dreier, Stefan Reinelt, et al.
Chemico-Biological Interactions|July 1, 1979
Chemical and ultrastructural examination of lead-induced morphological convertants of Bacillus subtilisW Barrow, T G Tornabene
Research in Microbiology|March 1, 1994
Laboratory and clinical aspects of the Mycobacterium avium epidemic: contributing factors associated with variability of drug susceptibility and immune responsiveness, and the multifaceted nature of pathogenicityN Rastogi, W W Barrow
Pageof 9